Back to Top

Ask about this Application


Benchling & Jounce Therapeutics: Migrating to an All-in-One Cloud Solution Saves Time on Data Management


Aug 24, 2021


Jounce Therapeutics uses a number of different analytical techniques to identify biomarkers in the tumor microenvironment (TME) that can help them match their drug candidates with the right patients. But they needed a way to manage all their assay and antibody data from concept to IND across different teams. Learn how Benchling unified Jounce's digital infrastructure to improve productivity and collaboration, and achieve a 100% software adoption rate.

Application File

Benchling & Jounce Case Study.pdf


Be the first to comment.

Submit a Comment

First Name *

Last Name *

Email *

Comments *

By submitting this form, you agree to the Genetic Engineering & Biotechnology News (GEN) privacy policy.

Premier Sponsor